REL-2-((1R,2S)-1-ETHYL-2-(PHENYLMETHOXY)PROPYL)-2,4-DIHYDRO-4-(4-(4-(4-HYDROXYPHENYL)-1-PIPERAZINYL)PHENYL)-3H-1,2,4-TRIAZOL-3-ONE
UNII CLK4CGR37E
Substance Identification & Data
This profile provides standardized clinical and technical data for Rel-2-((1r,2s)-1-ethyl-2-(phenylmethoxy)propyl)-2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-3h-1,2,4-triazol-3-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CLK4CGR37E.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2125944-53-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C30H35N5O3 QLRPRKJUMRQTOV-MUAVYFROSA-N;QLRPRKJUMRQTOV-BTYSJIOQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Rel-2-((1r,2s)-1-ethyl-2-(phenylmethoxy)propyl)-2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-3h-1,2,4-triazol-3-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.